Palavra-chave: AUTOLOGOUS STEM CELL TRANSPLANTATION

REFRACTORY LYMPHOMAS DATA META-ANALYSIS THALIDOMIDE HIGH DOSE CHEMOTHERAPY HODGKIN LYMPHOMA HODGKIN S LYMPHOMA ADVANCED MULTIPLE MYELOMA EBMT PROGRESSION-FREE SURVIVAL DEXAMETHASONE NON HODGKIN LYMPHOMA NON-HODGKIN´S LYMPHOMA INTERNATIONAL MYELOMA WORKING GROUP RITUXIMABE RETROSPECTIVE STUDY HIGH DOSE SEQUENTIAL CHEMO-RADIOTHERAPY SALVAGE APPROACHES RELAPSE MULTIPLE MYELOMA CHEMOTHERAPY THALIDOMIDE DEXAMETHASONE HODGKINS LYMPHOMA 462 PATIENTS NON-HODGKIN´S LYMPHOMAS B CELL LYMPHOMA CD34+ RANDOMIZED STUDY HIGH DOSE CYCLOPHOSPHAMIDE